(Q39432065)

11 September 2017

title

Efficacy and safety of oral estriol for managing postmenopausal symptoms (English)

1 reference

11 September 2017

Takahashi K

1

1 reference

11 September 2017

Manabe A

2

1 reference

11 September 2017

Okada M

3

1 reference

11 September 2017

Kurioka H

4

1 reference

11 September 2017

Kanasaki H

5

1 reference

11 September 2017

Miyazaki K

6

1 reference

11 September 2017

publication date

1 February 2000

1 reference

11 September 2017

1 reference

11 September 2017

volume

34

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

169-177

1 reference

Association of Exogenous Estrogen and Endometrial Carcinoma

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age- and body size-matched premenopausal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Estriol in the Management of the Menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Contemporary therapy of the menopausal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Bioavailability of oestriol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Pharmacokinetics of oestrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

The effect of oral estriol succinate therapy on the endometrial morphology in postmenopausal women: the significance of fractionation of the dose

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Cause-specific mortality in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Effect of continuous oral administration of estriol on corpus luteum function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Estrogen in prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

[Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women]

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900108-5

7 January 2021

10.1016/S0378-5122(99)00108-5

Identifiers

DOI

1 reference

11 September 2017

1 reference